Only 8% of major preventable adverse events after hip arthroplasty are filed as claims: a Swedish multi-center cohort study on 1,998 patients.


Journal

Acta orthopaedica
ISSN: 1745-3682
Titre abrégé: Acta Orthop
Pays: Sweden
ID NLM: 101231512

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 17 10 2019
medline: 28 4 2020
entrez: 17 10 2019
Statut: ppublish

Résumé

Background and purpose - Hip arthroplasty is one of the most performed surgeries in Sweden, and the rate of adverse events (AEs) is fairly high. All patients in publicly financed healthcare in Sweden are insured by the Mutual Insurance Company of Swedish County Councils (Löf). We assessed the proportion of patients that sustained a major preventable AE and filed an AE claim to Löf.Patients and methods - We performed retrospective record review using the Global Trigger Tool to identify AEs in a Swedish multi-center cohort consisting of 1,998 patients with a total or hemi hip arthroplasty. We compared the major preventable AEs with all patient-reported claims to Löf from the same cohort and calculated the proportion of filed claims.Results - We found 1,066 major preventable AEs in 744 patients. Löf received 62 claims for these AEs, resulting in a claim proportion of 8%. 58 of the 62 claims were accepted by Löf and received compensation. The claim proportion was 13% for the elective patients and 0.3% for the acute patients. The most common AE for filing a claim was periprosthetic joint infection; of the 150 infections found 37 were claimed.Interpretation - The proportion of filed claims for major preventable AEs is very low, even for obvious and serious AEs such as periprosthetic joint infection.

Identifiants

pubmed: 31615309
doi: 10.1080/17453674.2019.1677382
pmc: PMC7006721
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-25

Références

Bone Joint J. 2017 Aug;99-B(8):1088-1094
pubmed: 28768787
Acta Orthop. 2018 Aug;89(4):394-398
pubmed: 29808747
BMJ Open. 2019 Mar 7;9(3):e023773
pubmed: 30850403
Acta Orthop. 2016 Jun;87(3):209-17
pubmed: 26808350
Acta Orthop. 2017 Aug;88(4):383-389
pubmed: 28271919
Clin Orthop Relat Res. 2012 Feb;470(2):490-6
pubmed: 21796477
J Arthroplasty. 2018 Oct;33(10):3206-3210
pubmed: 29914820
Infect Control Hosp Epidemiol. 2014 Dec;35(12):1491-6
pubmed: 25419771
J Arthroplasty. 2016 Mar;31(3):596-602
pubmed: 26507527
Int J Qual Health Care. 2009 Aug;21(4):301-7
pubmed: 19617381
Health Aff (Millwood). 2011 Apr;30(4):581-9
pubmed: 21471476
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213

Auteurs

Martin Magnéli (M)

Department of Clinical Sciences at Danderyd Hospital, Division of Orthopaedics, Karolinska Institutet, Stockholm.

Maria Unbeck (M)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm.

Bodil Samuelsson (B)

Department of Clinical Sciences at Danderyd Hospital, Division of Orthopaedics, Karolinska Institutet, Stockholm.

Cecilia Rogmark (C)

Department of Clinical Sciences Malmö, Lund University Clinical and Molecular Osteoporosis Research Unit, Malmö.

Ola Rolfson (O)

Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.

Max Gordon (M)

Department of Clinical Sciences at Danderyd Hospital, Division of Orthopaedics, Karolinska Institutet, Stockholm.

Olof Sköldenberg (O)

Department of Clinical Sciences at Danderyd Hospital, Division of Orthopaedics, Karolinska Institutet, Stockholm.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH